skip to main content

European Commission

en

Search

Search

Newsroom

Menu

EMA newsletters
Archives

Overview News

Rheumatology

Rheumatology

date: 02/04/2025

New medicines recommended for approval

Osvyrti (denosumab) biosimilar
Treatment of osteoporosis

This service is managed by the Directorate-General for "Communications Networks, Content and Technology"

Newsroom

Cookies
Privacy policy
Legal notice

About Us

Directorate-General CONNECT